(HealthDay)—Non-vitamin K oral anticoagulants (NOACs) have a superior benefit-risk profile to that of vitamin K antagonists (VKAs) for patients with early-stage chronic kidney disease (CKD), according to a review published ...
Jul 16, 2019
0
1
Atrial fibrillation (AF) is linked to an increased risk of dementia, even in people who have not suffered a stroke, according to the largest study to investigate the association in an elderly population.
Jun 18, 2019
0
8
(HealthDay)—Black patients with atrial fibrillation are less likely to receive direct-acting oral anticoagulants (DOACs) compared with white patients, even after controlling for clinical and sociodemographic features, according ...
Dec 21, 2018
0
0
The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable ...
Sep 24, 2018
0
0
Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for antiplatelets, according ...
Aug 28, 2018
0
0
Among patients with nonvalvular atrial fibrillation, concurrent use of certain commonly prescribed medications with non-vitamin K oral anticoagulants was associated with an increased risk of major bleeding, according to a ...
Oct 3, 2017
0
0
Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF ...
Aug 28, 2017
0
0
The first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease is published online today in European Heart Journal, and on the ESC website. The document was developed in collaboration with the European ...
Aug 26, 2017
0
0
(HealthDay)—Electronic-health-based management of oral anticoagulation (OAC) therapy is associated with fewer adverse events, according to a study published online April 29 in the Journal of Thrombosis and Haemostasis.
May 7, 2017
0
0
In a new analysis, patients with atrial fibrillation showed a substantially reduced risk of dangerous bleeding in the brain, known as intracranial hemorrhage, when taking the newer anticoagulant apixaban compared to those ...
Mar 29, 2017
0
0
